Eating Disorders Clinical Trials

19 studies are recruiting for eating disorders in the United States right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

By city

Studies now recruiting

  1. Study Comparing Acceptance and Commitment Therapy to Supportive Diabetes Counseling and a Waitlist Control for Eating Disorders in Type 1 Diabetes

    The goal of this clinical trial is to test whether a new intervention works to treat eating disorders in type 1 diabetes. Participants are assigned to one of the following: (1) Acceptance and Commitment Therapy (ACT), (2) Supportive Diabetes Counseling, or (3) a 6-month Waitlist Control. Participan…

    Stage
    Not phased
    Ages
    16 to 50
    Site
    Duke University, Durham, North Carolina
    Locations
    2 in total
    Run by
    Duke University
  2. FlexED: National Substudy

    The purpose of this study is to test the feasibility of disseminating an intervention broadly. "FlexED" is a digital gamified intervention targeting eating disorder symptoms in young women and girls at risk by changing how they experience thoughts and feelings about their body. The digital interven…

    Stage
    Not phased
    Ages
    18 to 25
    Site
    Duke University Medical Center, Durham, North Carolina
    Run by
    Duke University
  3. FlexED: Full Threshold ED Substudy

    The purpose of this study is to test whether a new digital intervention decreases eating disorder symptoms in young women with eating disorders by changing how they experience thoughts and feelings about their body. The digital intervention is based on Acceptance and Commitment Therapy (ACT). Parti…

    Stage
    Not phased
    Ages
    15 to 25
    Site
    Duke University, Durham, North Carolina
    Run by
    Duke University
  4. A Randomized Controlled Trial Testing a Digital, Gamified Early Intervention for Eating Disorders ("FlexED")

    The goal of this clinical trial is to test whether a new digital intervention decreases eating disorder symptoms in young women and girls at risk by changing how they experience thoughts and feelings about their body. The digital intervention is based on Acceptance and Commitment Therapy (ACT). Par…

    Stage
    Not phased
    Ages
    15 to 25
    Site
    Duke University, Durham, North Carolina
    Run by
    Duke University
  5. Non-invasive Cranial Electrical Stimulation for Mealtime Anxiety in Adults With Eating Disorders

    The study is to evaluate the feasibility of using a non-invasive brain stimulation device in a sample of inpatients with eating disorders (ED). The study will help researchers evaluate whether their device protocol is practical for eating disorder inpatients as a way to manage eating disorder and a…

    Stage
    Not phased
    Ages
    18 to 30
    Site
    Rogers Behavioral Health, Oconomowoc, Wisconsin
    Run by
    Rogers Behavioral Health
  6. Tirzepatide Impact Assessment Study

    This study examines how two different weight-loss strategies affect heart and metabolic health, as well as changes at the molecular level in the body. One group includes adults who are starting a GLP-1 receptor agonist medication (i.e., semaglutide or tirzepatide) prescribed by their own doctor for…

    Stage
    Not phased
    Ages
    18 and older
    Site
    Nutrition Metabolic Health Initiative (NMHI), Lubbock, Texas
    Run by
    Texas Tech University
  7. Eating Disorder Chatbot Optimization

    The purpose of this study is to optimize an automated digital chatbot intervention for adults with clinical or subclinical eating disorders.

    Stage
    Phase 2
    Ages
    18 and older
    Site
    Washington University in St. Louis, St Louis, Missouri
    Run by
    Washington University School of Medicine
  8. Targeting Transdiagnostic Self-regulatory Factors and Eating Disorder Pathology Among Adults With BInge-spectrum Eating disOrders: A mHEALTH Interoceptive Exposure Intervention (the Bio-HEALTH Study)

    The present study will be fully remote (virtual) and include observational design features (assessments) plus a clinical trial. All assessments will be completed using HIPAA-approved platforms (e.g., Qualtrics, MindLogger EMA platform). After screening via Qualtrics to determine eligibility (descri…

    Stage
    Not phased
    Ages
    18 to 64
    Site
    University of Minnesota, Minneapolis, Minnesota
    Run by
    University of Minnesota
  9. Eating Disorder Dynamic Intervention

    The goal of this study is to develop and test a digital program to help people with eating disorders in their everyday lives. The program uses brief surveys and sensor data collected by smartphones to understand when someone may be at higher risk for behaviors like restricting food, binge eating, o…

    Stage
    Not phased
    Ages
    18 to 70
    Site
    Dartmouth College, Lebanon, New Hampshire
    Run by
    Trustees of Dartmouth College
  10. Safety Behavior Fading Versus Progressive Muscle Relaxation for Appearance Concerns

    The current study aims to explore the efficacy of a text message based safety behavior fading intervention compared to a progressive muscle relaxation intervention for appearance concerns.

    Stage
    Not phased
    Ages
    18 to 65
    Site
    Florida State University, Tallahassee, Florida
    Run by
    Florida State University
  11. A Precision Medicine Approach to Target Engagement for Emotion Regulation

    The proposed study is designed to first test whether teaching people personalized or standardized emotion regulation skills leads to greater decreases in daily negative emotion intensity. Second, using data from an initial sample, the investigators will prospectively assign an independent sample of…

    Stage
    Not phased
    Ages
    18 and older
    Site
    Ohio State University, Columbus, Ohio
    Run by
    Matthew Southward, PhD
  12. Targeting Social Function in Anxiety and Eating Disorders

    Social processing and cognition are often altered in patients with eating disorders. The goal of this clinical trial is to assess two different social therapeutic interventions -- one educational, one interactive -- for their effectiveness in improving clinical outcomes in patients with eating diso…

    Stage
    Not phased
    Ages
    18 to 30
    Site
    UT Southwestern Multispecialty Psychiatry Clinic, Dallas, Texas
    Run by
    University of Texas Southwestern Medical Center
  13. Developing an Artificial Intelligence (AI) Chatbot for Adolescents and Young Adults With Eating Disorders

    The goal of this study is to develop and refine an artificial intelligence (AI)-powered Exposure Therapy for Eating Disorders chatbot web-app that effectively engages adolescents and young adults and decreases anxiety about weight gain. Participants will use the web-app as a supplemental therapeuti…

    Stage
    Not phased
    Ages
    12 to 26
    Site
    Penn State College of Medicine, Hershey, Pennsylvania
    Run by
    Milton S. Hershey Medical Center
  14. Diabetes Body Project 2

    The purpose of this study is to test the feasibility and effectiveness of an eating disorder prevention program specifically targeted for women with type 2 diabetes (T2D) called the Diabetes Body Project 2 (DBP2). The Diabetes Body Project 2 (DBP2) will be adapted from the Diabetes Body Project, wh…

    Stage
    Not phased
    Ages
    18 to 40
    Site
    Joslin Diabetes Center, Boston, Massachusetts
    Run by
    Joslin Diabetes Center
  15. Neurostimulation Versus Therapy for Problems With Emotions

    The primary goal of this clinical trial is to evaluate the unique neural and behavioral effects of a one-session training combining emotion regulation skills training, with excitatory repetitive transcranial magnetic stimulation (rTMS) over the dorsolateral prefrontal cortex (dlPFC). The secondary …

    Stage
    Not phased
    Ages
    18 to 55
    Site
    Duke University Medical Center, Durham, North Carolina
    Run by
    Duke University
  16. Barrett's Esophagitis in Anorexia Nervosa Binge/Purge Subtype

    To better define the presence of Barrett's esophagus (BE) via non-endoscopic testing in an eating disorder cohort with purging (vomiting/rumination) behaviors

    Stage
    Not phased
    Ages
    18 to 65
    Site
    ACUTE Center for Eating Disorders and Severe Malnutrition, Denver, Colorado
    Locations
    3 in total
    Run by
    Denver Health and Hospital Authority
  17. Naltrexone Neuroimaging in Teens With Eating Disorders

    Using a randomized, placebo-controlled, crossover study, this study will evaluate functional magnetic resonance imaging (fMRI) as a pharmacodynamic biomarker of opioid antagonism in adolescents with eating disorders. The hypothesis is that fMRI will be able to detect acute reward pathway modulation…

    Stage
    EARLY_Phase 1
    Ages
    13 to 21
    Site
    Children's Mercy Research Institute, Kansas City, Missouri
    Run by
    Children's Mercy Hospital Kansas City
  18. Innovations in Personalizing Treatment Study

    Eating disorders (EDs) are serious mental illness: someone dies of an ED every 52 minutes. EDs are highly related to a host of negative outcomes, including public health and individual disease burden, medical and psychological comorbidities, and social determinants of health (SDOH). Treatment respo…

    Stage
    Not phased
    Ages
    18 to 65
    Site
    Eating Anxiety Laboratory and Clinic, Louisville, Kentucky
    Run by
    University of Louisville
  19. Open vs. Blind Weighing Study In Adolescents and Young Adult With Eating Disorders

    Current treatments for adolescents and young adults (AYAs) with eating disorders (EDs) do not effectively address a central ED symptom - anxiety about weight gain - which contributes to poor outcomes. The proposed study evaluates the feasibility, acceptability, efficacy, and underlying mechanisms o…

    Stage
    Not phased
    Ages
    12 to 24
    Site
    905 W Govener Rd, Hershey, Pennsylvania
    Run by
    Milton S. Hershey Medical Center

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.